CD47 and prostate neoplasm: Consistent with the data in Figure 6A, prostate tumors with low SLFN11 mRNA (z-score < 0) were enriched in the quadrant with low CD47 mRNA (34% CD47 z-score < 0 vs. 26% z-score >0, Figure 9A).